◆英語タイトル：Octapharma AG - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C4465
◆発行会社（調査会社）：
MarketLine
◆発行日：2018年8月
◆ページ数：34
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：スイス
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
MarketLine社の概要はこちらでご確認いただけます。
Octapharma AG – Strategy, SWOT and Corporate Finance Report
Summary
Octapharma AG – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Octapharma AG (Octapharma or ‘the company’) is a human proteins manufacturer involved in the development and sale of human proteins for use in pharmaceuticals and medical treatments. Its product portfolio comprises of protein and other biopharmaceutical products derived from human plasma in three therapeutic areas: haematology, critical care, and immunotherapy. The company operates manufacturing facilities in Austria, France, Sweden, Germany, and Mexico. In addition, its research and development (R&D) facilities are also involved in research and development of human proteins for various therapeutic areas. The company operates through its subsidiaries in Europe, North and South Americas, Asia Pacific and the Middle East. Octapharma is headquartered in Lachen, Switzerland.
Scope
- Detailed information on Octapharma AG required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Octapharma AG in the form of a SWOT analysis
- An in-depth view of the business model of Octapharma AG including a breakdown and examination of key business segments
- Intelligence on Octapharma AG’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Octapharma AG, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
- Gain understanding of Octapharma AG and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Octapharma AG as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Octapharma AG’s business structure, strategy and prospects.
Table of Contents
Company Snapshot 2
Table of Contents 4
Octapharma AG: Company Overview 8
Octapharma AG: Overview and Key Facts 8
Octapharma AG: Overview 8
Octapharma AG: Key Facts 8
Octapharma AG: Key Employees 9
Octapharma AG: Major Products and Services 10
Octapharma AG: Company History 11
Octapharma AG: Management Statement 14
Octapharma AG: Locations and Subsidiaries 16
Octapharma AG: Key Competitors 18
Octapharma AG: Company Analysis 19
Octapharma AG: Business Description 19
Octapharma AG: SWOT Analysis 20
Octapharma AG: SWOT Overview 20
Octapharma AG: Strengths 20
Octapharma AG: Weaknesses 20
Octapharma AG: Opportunities 21
Octapharma AG: Threats 21
Octapharma AG: Corporate Financial Deals Activity 23
Octapharma AG: Financial Deals Overview 23
Octapharma AG: Targets and Partners 24
Octapharma AG: Top Deals 2014 – 2018YTD* 25
Octapharma AG: Corporate Venturing 26
Octapharma AG: Partnership 27
Octapharma AG: Recent Developments 28
Octapharma AG: News and Events Summary 28
Octapharma AG: Financial Performance 29
Octapharma AG: Regulatory and Legal Events 30
Octapharma AG: Research & Development 30
Appendix 32
Contact Us 32
Methodology 32
About MarketLine 33
List of Tables
Table 1: Octapharma AG: Key Facts
Table 2: Octapharma AG: Key Employees
Table 3: Octapharma AG: Locations and Subsidiaries
Table 4: Octapharma AG: Key Competitors
Table 5: Octapharma AG: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 6: Octapharma AG: Targets and Partners
Table 7: Octapharma AG: Top Deals 2014 - 2018YTD*
Table 8: Octapharma AG: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 9: Octapharma AG: Corporate Venturing by Geography (2014 - YTD*2018)
Table 10: Octapharma AG: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 11: Octapharma AG: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 12: Octapharma AG: News and Events Summary
Table 13: Octapharma AG: Financial Performance
Table 14: Octapharma AG: Regulatory and Legal Events
Table 15: Octapharma AG: Research & Development
List of Figures
Figure 1: Octapharma AG: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: Octapharma AG: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 3: Octapharma AG: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 4: Octapharma AG: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 5: Octapharma AG: Partnership Trend by Deal Type (2014 - YTD*2018)
